Navigation Links
Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
Date:1/26/2010

TEANECK, N.J., Jan. 26 /PRNewswire/ -- Amy Yueh, the organizer of the Pharma CI Conference, who was sued in 2008 for alleged misappropriation of her employer's assets, has made payment of $52,000 by court order following judgment entered against her in the Superior Court of New Jersey. Yueh's trial took place in Hackensack, NJ.

Ellen Koblitz, Presiding Judge of the Superior Court of New Jersey stated in her ruling that Yueh "clearly took advantage of her employer by misleading 2008 conference participants." The decision represents compensation for "lost opportunity to compete on a level playing field had Yueh left and set up her own conference without misleading the potential participants."

In reaching decision, Judge Koblitz heard 3 1/2 days of testimony by Amy Yueh under questioning by lawyers for the prosecution. The Judge also accepted the introduction of testimony provided in depositions by former SCIP (Society of Competitive Intelligence Professionals) Presidents Cliff Kalb and Martha Matteo.

Yueh's motion to introduce testimony by Steve Levy of Fletcher CSI and her sister, Kelly Yueh, was denied by Judge Koblitz.

As part of the pre-trial proceedings counsel at Pfizer, Johnson & Johnson, Merck, sanofi-aventis, Bristol-Myers Squibb, and Novartis were subpoenaed in request of files detailing Yueh's email communications with various employees within the companies. The drug firms were helpful and the information provided was also recovered from her computer by forensic experts.

Previous articles and press releases on the case may be found at:

http://news.findlaw.com/prnewswire/20080813/13aug20080904.html

http://www.genengnews.com/news/bnitem.aspx?name=41654272

http://www.prnewswire.com/news-releases/50000-judgment-entered-against-defendant-amy-yueh-pharma-ci-conference-organizer-in-superior-court-of-new-jersey-62134257.html

http://www.njbiz.com/article.asp?aID=79155

Amy Yueh revealed in court documents that the 2008 Pharma CI Conference had revenues of $417,145 and net profits of $285,156.

The legal action was initiated in the Superior Court of New Jersey against Amy Yueh and her companies Acralinx Agenda and Amintell LLC.

Further litigation is pending.

CONTACT:  Mark Alexay, +1-201-452-4023, malexay@pharmabiotechci.com

SOURCE Apaporis LLC


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/24/2017)... July 24, 2017 IBM (NYSE: IBM ) ... Quadrant for Solid-State Arrays (SSA) for the fourth year in ... According to Gartner, "Vendors in the Leaders quadrant have the ... Vision. A vendor in the Leaders quadrant has the market ... the acceptance of new technologies. These vendors demonstrate a clear ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc ... completing a comprehensive review of its manufacturing network, the ... and distribution facilities in Huntsville, Alabama ... take place over the next 12 to 18 months. ... impacted by declining volumes of commoditized products and these ...
Breaking Medicine Technology:
(Date:7/28/2017)... Wheaton, IL (PRWEB) , ... July 28, 2017 , ... ... recently announced the hiring of associate Jennifer M. Cusack. Ms. Cusack joins ... areas. , Ms. Cusack graduated from Bradley University in Peoria, Illinois, with ...
(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... ... protection and financial planning assistance to families and business owners in and around ... to be held in honor of the Make-A-Wish Foundation. , The Make-A-Wish Foundation ...
(Date:7/27/2017)... ... July 27, 2017 , ... Dr. Adam ... of Oral Implantology/Implant Dentistry (ABOI/ID). After successfully completing an extensive two-day examination in ... dental implants . Dr. Kimowitz and his partner Dr. Hal Kimowitz, practice ...
(Date:7/27/2017)... ... 27, 2017 , ... TransPanel Volume 4 is a collection of animating panel ... exclusive features transitions that contain between 2 and 6 animated panels. Change the direction ... menus. TransPanel Volume 4 makes editing easy in Final Cut Pro X. , TransPanel ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... services, announces the internal promotion of Elrene Clinkscales to Vice President of Revenue ... & Remittance Management, reporting to Derek Morkel, chief executive officer (CEO). , Elrene ...
Breaking Medicine News(10 mins):